MAPT and Alzheimer disease: While previous studies have shown elevated plasma t-tau concentrations in AD patients compared to controls [29–33], the lack or weak correlations between CSF and plasma tau levels [29, 34], and the considerable overlap between groups [29, 35] hinders clinical translation.